Skip to main content
. 2020 Mar 14;34(3):401–417. doi: 10.1007/s10557-020-06959-1

Fig. 4.

Fig. 4

Changes in cardiac phosphodiesterase expression during heart failure and pharmacological modulators. Phosphodiesterases (PDEs) 1, 2, 3, 4, 5 and 9 contribute to the pathophysiology of heart failure (HF). Arrows indicate changes in PDE expression during HF. Blunt lines indicate inhibition with selective pharmacological modulators